InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,195.89
(
0.29%
)
US TECH 100
17,664.40
(
0.31%
)
Dow Jones
38,934.49
(
0.21%
)
Brent Oil
82.95
(
-0.63%
)
Bitcoin
63,798.65
(
1.00%
)
Post# of 110
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

trendzone

Send PM Follow Ignore
Followers 57
Posts 4855
Boards Moderated 0
Alias Born 02/11/2020

trendzone

Re: None

Monday, 11/29/2021 5:12:33 PM

Monday, November 29, 2021 5:12:33 PM

Post# of 110
Petros Pharma, Qualigen see dramatic rises amid social media buzz, short squeezes

Nov. 29, 2021 2:34 PM ETQualigen Therapeutics, Inc. (QLGN), PTPIBy: Jonathan M Block, SA News Editor1 Comment

?

Vertigo3d/E+ via Getty Images

Microcaps Petros Pharmaceuticals (PTPI +104.3%) and Qualigen Therapeutics (QLGN +24.4%) are among the best performing biotechs today as discussion of the companies accelerates on social media and potential short squeezes taking place.

Message volume on Stocktwits for Petros is up 94% more than average. Stock volume in Petros, as of 2:30 PM, is ~201.6M shares. Average daily volume is 6.6M shares.

By comparison, Qualigen is seeing a more modest upswing. Volume as of 2:30 PM is ~35.8M shares. Average daily volume is ~5.3M shares.

Petros shares surged last week after announcing its annual shareholder meeting for next month.

Now Read: Qualigen Therapeutics EPS beats by $0.11, misses on revenue

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent QLGN News
More QLGN News
InvestorsHub NewsWire

FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM

Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Start posting your company's news
Only $200 per official company press release!